Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Breast Neoplasms 2 Urologic Neoplasms 1 Urologic Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Urinary Bladder Diseases 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm Metastasis 1 Male Urogenital Diseases 1 Lymphedema 1 Lung Neoplasms 1 Gallbladder Neoplasms 1 Financial Stress 1 Female Urogenital Diseases 1 Endometrial Neoplasms 1 Encopresis 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

Temozolomide 7 Vincristine 5 X-Rays 4 Specimen Handling 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Irinotecan 4 Cyclophosphamide 4 cabozantinib 3 Ifosfamide 3 Etoposide 3 Doxorubicin 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 liposomal doxorubicin 2 ivosidenib 2 Topotecan 2 Radiation 2 Nuclear Medicine Department, Hospital 2 LY3023414 2 Eflornithine 2 Congresses as Topic 2 trifluridine tipiracil drug combination 1 talazoparib 1 silmitasertib 1 romiplostim 1 regorafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Ewing × Radiation Dose Hypofractionation × 90 days × Clear all

NCT07188532 2026-06-04

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡